Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Workers - Hazard via inhalation route

Systemic effects

Long term exposure
Hazard assessment conclusion:
DNEL (Derived No Effect Level)
Value:
0.09 mg/m³
Most sensitive endpoint:
repeated dose toxicity
Route of original study:
Oral
DNEL related information
DNEL derivation method:
ECHA REACH Guidance
Overall assessment factor (AF):
50
Dose descriptor starting point:
NOAEL
Value:
5 mg/kg bw/day
Modified dose descriptor starting point:
NOAEC
Value:
4.4 mg/m³
Explanation for the modification of the dose descriptor starting point:

NOEChuman= NOELrat× (1/0.38 m3/kg bw) × (6.7m3/10m3) × (oral absorption/inhalation absorption) = 5 mg/kg bw/day × 1/0.38 × 6.7/10 × 50/100

AF for dose response relationship:
1
Justification:
Default - NOAEL defined
AF for differences in duration of exposure:
2
Justification:
Default - subchronic to chronic
AF for interspecies differences (allometric scaling):
1
Justification:
No allometric scalling is required for inhalation
AF for other interspecies differences:
1
Justification:
Addressed by modification of starting point
AF for intraspecies differences:
5
Justification:
Default for workers
AF for the quality of the whole database:
2
Justification:
Data from source substance
AF for remaining uncertainties:
2.5
Justification:
default- remaining differences
Acute/short term exposure
Hazard assessment conclusion:
no hazard identified
DNEL related information

Local effects

Long term exposure
Hazard assessment conclusion:
no hazard identified
Acute/short term exposure
Hazard assessment conclusion:
no hazard identified
DNEL related information

Workers - Hazard via dermal route

Systemic effects

Long term exposure
Hazard assessment conclusion:
DNEL (Derived No Effect Level)
Value:
0.05 mg/kg bw/day
Most sensitive endpoint:
repeated dose toxicity
Route of original study:
Oral
DNEL related information
DNEL derivation method:
ECHA REACH Guidance
Overall assessment factor (AF):
200
Dose descriptor starting point:
NOAEL
Value:
5 mg/kg bw/day
Modified dose descriptor starting point:
NOAEL
Value:
10 mg/kg bw/day
Explanation for the modification of the dose descriptor starting point:

NOELhuman= NOELrat× (oral absorption/dermal absorption) = 5 mg/kg bw/day × (50%/25%)

AF for dose response relationship:
1
Justification:
Default - NOAEL defined
AF for differences in duration of exposure:
2
Justification:
Default - subchronic to chronic
AF for interspecies differences (allometric scaling):
4
Justification:
Default – rat to human
AF for other interspecies differences:
1
Justification:
Addressed by modification of starting point
AF for intraspecies differences:
5
Justification:
Default for workers
AF for the quality of the whole database:
2
Justification:
Data from source substance
AF for remaining uncertainties:
2.5
Justification:
Default- remaining differences
Acute/short term exposure
Hazard assessment conclusion:
no hazard identified
DNEL related information

Local effects

Long term exposure
Hazard assessment conclusion:
medium hazard (no threshold derived)
Acute/short term exposure
Hazard assessment conclusion:
medium hazard (no threshold derived)

Workers - Hazard for the eyes

Local effects

Hazard assessment conclusion:
no hazard identified

Additional information - workers

Repeated dose toxicity studies with Uvicure S128 are not available, therefore read-across to the source substance 7-oxabicyclo[4.1.0]hept-3-ylmethyl 7-oxabicyclo[4.1.0]heptane-3-carboxylate (CAS Number:2386-87-0;EC Number:219-207-4) based on the presence of same functional groups and close structural similarity.

The oral repeat-dose 90-day study in rats with the source substance resulted in a NOAEL of 5 mg/kg bw/day and did identify a systemic effect in nasal epithelium, suggesting that effects observed in the target organ following oral dosing could potentially be elicited by systemic exposure. In addition, the substance is not acutely toxic, is neither a skin nor an eye irritant. Genotoxic potential was evidenced in available studies. The NOAEL of 5 mg/kg bw/day has been used as the starting point for long-term systemic DNELs derivation and is considered protective enough for workers.

The substance is a skin sensitiser, but no DNEL/DMEL can be derived, since skin sensitisation was tested in a M&K test. A qualitative assessment has been performed and according to Table R. 8-24 (Chapter R.8, ECHA Guidance on information requirements and chemical safety assessment), the substance is considered to be a moderate skin sensitiser.

General Population - Hazard via inhalation route

Systemic effects

Long term exposure
Hazard assessment conclusion:
no hazard identified
Acute/short term exposure
Hazard assessment conclusion:
no hazard identified
DNEL related information

Local effects

Long term exposure
Hazard assessment conclusion:
no hazard identified
Acute/short term exposure
Hazard assessment conclusion:
no hazard identified
DNEL related information

General Population - Hazard via dermal route

Systemic effects

Long term exposure
Hazard assessment conclusion:
no hazard identified
Acute/short term exposure
Hazard assessment conclusion:
no hazard identified
DNEL related information

Local effects

Long term exposure
Hazard assessment conclusion:
no hazard identified
Acute/short term exposure
Hazard assessment conclusion:
no hazard identified

General Population - Hazard via oral route

Systemic effects

Long term exposure
Hazard assessment conclusion:
no hazard identified
Acute/short term exposure
Hazard assessment conclusion:
no hazard identified
DNEL related information

General Population - Hazard for the eyes

Local effects

Hazard assessment conclusion:
no hazard identified

Additional information - General Population

No general public exposure is anticipated.